206 related articles for article (PubMed ID: 1860303)
1. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance of 100 serial gram-negative isolates in two intensive care units.
Leelarasamee A; Janyapoon K
J Med Assoc Thai; 1992 Dec; 75(12):680-7. PubMed ID: 1308536
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
[TBL] [Abstract][Full Text] [Related]
4. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
5. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
8. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin-resistant Pseudomonas keratitis.
Garg P; Sharma S; Rao GN
Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
[TBL] [Abstract][Full Text] [Related]
10. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
Sueke H; Kaye S; Neal T; Murphy C; Hall A; Whittaker D; Tuft S; Parry C
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
[TBL] [Abstract][Full Text] [Related]
11. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli.
Somily AM
Saudi Med J; 2010 May; 31(5):507-11. PubMed ID: 20464039
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
Visalli MA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Pfaller MA; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
[TBL] [Abstract][Full Text] [Related]
16. [Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Rodríguez CH; Juárez J; de Mier C; Pugliese L; Blanco G; Vay C; Famiglietti A
Medicina (B Aires); 2003; 63(1):21-7. PubMed ID: 12673956
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
Ismaeel NA
Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of colistin in gram-negative bacteria.
Tan TY; Ng SY
Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2008 Feb; 61(2):371-4. PubMed ID: 18033780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]